Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

The Morgan Stanley executive is retiring to run a foundation she started that aims to bring more young women into wealth ...

The stock's fall snapped a four-day winning streak.

We recently compiled a list of the 10 AI News You Can’t Miss. In this article, we are going to take a look at where Broadcom ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

A portfolio of Brightview Senior Living communities spanning four markets, including Philadelphia, has sold to one of America ...

Nvidia’s (NASDAQ:NVDA) seemingly never-ending surge has been more muted in recent times. While sentiment has far from soured ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

Morgan Stanley’s stock (NYSE: MS) gained over 30% year-to-date. This compares to rival Goldman Sachs stock, which has seen ...